We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.32B
AUM Growth
+$155M
Cap. Flow
-$100M
Cap. Flow %
-1.89%
Top 10 Hldgs %
16.3%
Holding
739
New
50
Increased
312
Reduced
249
Closed
35

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$31M
2
CL icon
Colgate-Palmolive
CL
+$20M
3
MRK icon
Merck
MRK
+$18.8M
4
GLW icon
Corning
GLW
+$18.5M
5
FFIV icon
F5
FFIV
+$17.2M

Sector Composition

Rank Sector Weight
1 Healthcare 25.58%
2 Technology 13.62%
3 Financials 13.2%
4 Consumer Discretionary 9.51%
5 Industrials 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BN icon
401
Brookfield
BN
$102B
$2.57M 0.05%
183,562
-48,569
-21% -$654K
PVH icon
402
PVH
PVH
$3.71B
$2.56M 0.05%
22,327
+16,999
+319% +$1.76M
TXMD icon
403
TherapeuticsMD
TXMD
$23.8M
$2.53M 0.05%
9,600
+3,000
+45% +$751K
PCRX icon
404
Pacira BioSciences
PCRX
$1.02B
$2.53M 0.05%
53,000
-7,000
-12% -$325K
RNAC icon
405
Cartesian Therapeutics
RNAC
$232M
$2.5M 0.05%
4,200
+3,167
+307% +$1.4M
NSC icon
406
Norfolk Southern
NSC
$78.8B
$2.48M 0.05%
20,361
-2,674
-12% -$314K
ONC
407
BeOne Medicines Ltd
ONC
$33.8B
$2.48M 0.05%
55,000
-60,000
-52% -$2.36M
FISV
408
Fiserv Inc
FISV
$27.2B
$2.47M 0.05%
40,388
+4,624
+13% +$280K
MCO icon
409
Moody's
MCO
$82.4B
$2.46M 0.05%
20,183
+1,933
+11% +$226K
NEM icon
410
Newmont
NEM
$99.5B
$2.44M 0.05%
75,452
-71,334
-49% -$2.4M
PSA icon
411
Public Storage
PSA
$60.2B
$2.44M 0.05%
11,681
+701
+6% +$151K
XEL icon
412
Xcel Energy
XEL
$51B
$2.43M 0.05%
52,978
+965
+2% +$44.4K
SQM icon
413
Sociedad Química y Minera de Chile
SQM
$19.6B
$2.41M 0.05%
73,000
+3,000
+4% +$105K
GWPH
414
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$2.41M 0.05%
24,000
+7,000
+41% +$753K
LEG icon
415
Leggett & Platt
LEG
$1.52B
$2.4M 0.05%
45,660
-9,426
-17% -$492K
WELL icon
416
Welltower
WELL
$178B
$2.38M 0.04%
31,791
+6,000
+23% +$439K
MTD icon
417
Mettler-Toledo International
MTD
$26.8B
$2.38M 0.04%
4,037
-261
-6% -$143K
CCI icon
418
Crown Castle
CCI
$32.7B
$2.37M 0.04%
23,647
+566
+2% +$55.6K
PCG icon
419
PG&E
PCG
$47.8B
$2.37M 0.04%
35,632
-37,744
-51% -$2.54M
PLD icon
420
Prologis
PLD
$138B
$2.33M 0.04%
39,714
+2,290
+6% +$128K
PXD
421
DELISTED
Pioneer Natural Resource Co.
PXD
$2.32M 0.04%
14,559
-1,210
-8% -$207K
S
422
DELISTED
Sprint Corporation
S
$2.32M 0.04%
282,603
-33,253
-11% -$276K
RSG icon
423
Republic Services
RSG
$66.7B
$2.32M 0.04%
36,354
+13,159
+57% +$833K
NLY icon
424
Annaly Capital Management
NLY
$16.9B
$2.31M 0.04%
47,919
+8,857
+23% +$418K
WAT icon
425
Waters Corp
WAT
$36.8B
$2.31M 0.04%
12,566
-1,103
-8% -$192K

Similar funds

Candriam SCA's Q2 2017 Portfolio in Review

As of Q2 2017, Candriam SCA held 739 positions worth $5.32B, up 3% from $5.17B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA's Q2 2017 filing shows 50 new, 312 increased, 249 reduced and 35 closed positions. Its largest new stake was Raymond James Financial: 164,790 shares worth $8.81M. The largest sale was PepsiCo, an estimated $40.4M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q2 2017 buy was Raymond James Financial: 164,790 shares worth $8.81M.
  • Candriam SCA added most to Kellanova in Q2 2017, an estimated $31M increase.
  • Candriam SCA's biggest Q2 2017 reduction was PepsiCo, cutting an estimated $40.4M.
  • Candriam SCA fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $20.4M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.32B portfolio in Q2 2017.
  • Candriam SCA opened 50 new positions and closed 35 in Q2 2017.
  • Candriam SCA's portfolio value rose 3% quarter-over-quarter to $5.32B.

Based on Candriam SCA's 13F filing for Q2 2017, filed 31 Jul 2017.